Skip to main content
. Author manuscript; available in PMC: 2020 May 24.
Published in final edited form as: Clin Cancer Res. 2019 Jan 7;25(9):2745–2754. doi: 10.1158/1078-0432.CCR-18-3310

Figure 3.

Figure 3.

Complementary elevations in primary tumors and plasma. A, Immunofluorescence staining showed expression of one, both, or neither of the markers. B, The quantification of tissue and plasma levels revealed low correspondence between the 2 markers. A substantial group of patients was elevated in only sTRA, based on thresholds set to the highest control samples (dashed lines), but the high correlation (0.74) was caused by one outlier value (arrowhead).